Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
Clinical trial NCT05596526 · UNKNOWN
Trial details
- NCT number
- NCT05596526
- Sponsor
- Prof Patrice Lalive
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.